{"gene":"STXBP5","run_date":"2026-04-28T21:42:57","timeline":{"discoveries":[{"year":1998,"finding":"Tomosyn (STXBP5) binds syntaxin-1, dissociates Munc18 from syntaxin-1, and forms a novel 10S complex with syntaxin-1, SNAP-25, and synaptotagmin; high-level expression reduces Ca2+-dependent exocytosis in PC12 cells","method":"Co-immunoprecipitation, biochemical fractionation, PC12 cell overexpression assay","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — original discovery paper with multiple orthogonal biochemical methods, highly cited, replicated by subsequent work","pmids":["9620695"],"is_preprint":false},{"year":2003,"finding":"The C-terminal R-SNARE motif of tomosyn forms a stable four-helical SNARE core complex with syntaxin-1 and SNAP-25, competing with synaptobrevin for SNARE complex formation and inhibiting exocytosis; complexes are disassembled by NSF/α-SNAP","method":"In vitro reconstitution with recombinant proteins, CD spectroscopy, inside-out plasma membrane sheets competition assay, PC12 cell exocytosis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with multiple orthogonal methods including structural characterization, replicated","pmids":["12782620"],"is_preprint":false},{"year":2004,"finding":"Crystal structure of the tomosyn SNARE core complex at 2.0-Å resolution reveals a four-helical bundle nearly identical to the synaptobrevin SNARE complex; synaptobrevin cannot displace the tomosyn helix and vice versa, indicating both represent stable end products","method":"X-ray crystallography, CD spectroscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional validation","pmids":["15316007"],"is_preprint":false},{"year":2004,"finding":"Tomosyn inhibits the priming step of large dense-core vesicle exocytosis in chromaffin cells in a calcium-dependent manner, reducing fusion-competent vesicle number without affecting docked vesicle number or single-vesicle fusion kinetics","method":"Morphological analysis, capacitance measurements, amperometry, chromaffin cell overexpression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal physiological methods, replicated concept across labs","pmids":["14983051"],"is_preprint":false},{"year":2004,"finding":"ROCK (activated by Rho GTPase) phosphorylates syntaxin-1, increasing its affinity for tomosyn and forming a stable tomosyn-syntaxin complex that inhibits SNARE complex formation; this localizes tomosyn to growth cone palms to regulate neurite extension and retraction","method":"Biochemical interaction assays, kinase assays, confocal microscopy of growth cones","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct biochemical evidence for phosphorylation-dependent interaction, single lab","pmids":["15240567"],"is_preprint":false},{"year":2005,"finding":"PKA directly phosphorylates tomosyn, reducing its interaction with syntaxin-1 and enhancing SNARE complex formation; this increases the readily releasable pool and neurotransmitter release in SCG neurons, mediating PACAP-induced synaptic facilitation","method":"In vitro kinase assay, co-immunoprecipitation, electrophysiology in cultured SCG neurons","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — direct phosphorylation assay combined with electrophysiology and interaction studies","pmids":["16186257"],"is_preprint":false},{"year":2006,"finding":"C. elegans TOM-1 (tomosyn ortholog) negatively regulates synaptic vesicle priming at the NMJ; tom-1 mutants show increased plasma membrane-contacting vesicles and enhanced hyperosmotic responses; tom-1 unc-13 double mutants partially suppress unc-13 priming defects","method":"Electrophysiology, electron microscopy ultrastructure, hyperosmotic response assay, genetic epistasis","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including epistasis, replicated concept","pmids":["16895441"],"is_preprint":false},{"year":2006,"finding":"Tomosyn-1 is expressed in pancreatic beta-cells, co-immunoprecipitates with syntaxin-1, and negatively regulates insulin exocytosis; siRNA knockdown increases exocytosis while overexpression decreases it","method":"Co-immunoprecipitation, siRNA knockdown, overexpression, exocytosis measurement","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP and functional KD/OE, single lab","pmids":["16505218"],"is_preprint":false},{"year":2006,"finding":"Tomosyn-1 in pancreatic beta-cells is involved in a post-docking event required for exocytosis; silencing tomosyn-1 does not affect docked granule number but reduces stimulus-induced exocytosis; the SNARE-like domain forms a complex with syntaxin-1 and SNAP-25 with weaker binding forces than VAMP2","method":"Atomic force microscopy, RNA interference, electron microscopy, exocytosis assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — AFM binding force measurement combined with functional RNAi, single lab","pmids":["16787939"],"is_preprint":false},{"year":2003,"finding":"Tomosyn interacts with t-SNAREs syntaxin-4 and SNAP-23 through its VAMP-2-like domain, forming a ternary complex competitively inhibited by VAMP-2; overexpression in adipocytes inhibits insulin-stimulated GLUT4 translocation to the plasma membrane","method":"Yeast two-hybrid, in vitro binding, GLUT4-GFP translocation assay in 3T3-L1 adipocytes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple binding assays plus cellular functional assay, single lab","pmids":["12832401"],"is_preprint":false},{"year":2008,"finding":"Tomosyn inhibits SNARE complex formation and neurotransmitter release through dual mechanisms: (1) C-terminal VAMP-like domain sequesters syntaxin-1; (2) N-terminal WD-40 repeat domain catalyzes oligomerization of SNARE complexes; microinjection of the WD-40 domain into neurons prevented stimulated acetylcholine release","method":"Microinjection, biochemical analysis of SNARE complex oligomerization, tomosyn-deficient mouse neurons","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — direct neuronal microinjection combined with biochemical analysis and genetic model","pmids":["18936251"],"is_preprint":false},{"year":2007,"finding":"Tomosyn WD-40 domain integrity (not the SNARE domain) is required for inhibition of vesicle priming; a truncation lacking the entire SNARE domain still inhibits exocytosis, while N-terminal truncations abolish inhibition despite retaining syntaxin binding","method":"Domain deletion mutant overexpression in chromaffin cells, capacitance measurements","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — structure-function analysis with multiple mutants and functional readout, single lab","pmids":["17666050"],"is_preprint":false},{"year":2007,"finding":"Secretagogue stimulation causes rapid translocation of tomosyn from cytosol to plasma membrane and increases tomosyn-syntaxin-1A interaction; this is mediated by RhoA/ROCK signaling, as ROCK inhibition blocks the secretagogue-induced tomosyn-syntaxin interaction","method":"Live-cell imaging, FRAP, co-immunoprecipitation, pharmacological inhibition in chromaffin cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — live imaging and biochemistry combined, single lab","pmids":["17545156"],"is_preprint":false},{"year":2011,"finding":"m-tomosyn-1 is a substrate for SUMO-2/3 conjugation; mutation of the SUMO target site (Lys-730) enhances tomosyn-1 inhibition of secretion without altering interaction with syntaxin-1A; loop domains 1 and 3 of the β-propeller core are required for inhibitory activity independent of SNARE pairing","method":"Site-directed mutagenesis, SUMO conjugation assay, secretion assay in PC12 cells, homology modeling","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with functional secretion readout, single lab","pmids":["21330375"],"is_preprint":false},{"year":2014,"finding":"STXBP5 is expressed in human endothelial cells, colocalizes and interacts with syntaxin-4; STXBP5 knockdown increases vWF and P-selectin exocytosis; Stxbp5 KO mice have elevated plasma vWF, increased platelet-endothelial interactions, but also impaired platelet secretion and hemostasis","method":"Co-immunoprecipitation, siRNA knockdown, Stxbp5 KO mouse model, tail bleeding, thrombosis assay","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including KO mouse with defined phenotypes","pmids":["25244095"],"is_preprint":false},{"year":2014,"finding":"STXBP5 (tomosyn-1) in platelets interacts with syntaxin-11/SNAP-23 heterodimers and the platelet cytoskeleton; Stxbp5 KO mice show defective secretion from all three granule types and altered granule cargo levels, demonstrating a role in platelet granule cargo packaging and secretion","method":"Mass spectrometry identification, co-immunoprecipitation, fractionation, Stxbp5 KO mouse, lumi-aggregometry, FACS","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — MS identification plus KO mouse with multiple functional readouts","pmids":["25244094"],"is_preprint":false},{"year":2014,"finding":"The C-terminal domain (CTD) of tomosyn mediates inhibition of SNARE-dependent membrane fusion by recognizing the t-SNARE complex and preventing v-SNARE pairing; the N-terminal domain (NTD) is required for binding to syntaxin monomer and recruitment to fusion sites; tomosyn inhibition is dominant over Munc18 stimulatory activity","method":"In vitro reconstituted liposome fusion assay, purified full-length and truncated proteins, binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified full-length protein and defined domain dissection","pmids":["25063806"],"is_preprint":false},{"year":2014,"finding":"Tomosyn-2 is phosphorylated in response to high glucose, phorbol esters, and cAMP analogs; phosphomimetic mutants show enhanced proteasomal degradation and reduced inhibition of insulin secretion; Hrd-1 E3 ubiquitin ligase binds tomosyn-2 and promotes its ubiquitination and degradation","method":"32P labeling, mass spectrometry, site-directed mutagenesis, proteomic screen, ubiquitination assay, shRNA knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — phosphorylation mapped by MS, mutagenesis, E3 ligase identified with functional validation","pmids":["25002582"],"is_preprint":false},{"year":2014,"finding":"Tomosyn is organized in small clusters adjacent to syntaxin clusters on the plasma membrane; tomosyn inhibition of exocytosis is mediated through tomosyn-syntaxin-SNAP25 ternary complexes rather than tomosyn-syntaxin binary complexes; WD-40 core residues 537-578 and 897-917 are required for SNAP25 binding","method":"dSTORM super-resolution microscopy, deletion mutant analysis, FRAP","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — super-resolution imaging combined with functional mutagenesis, single lab","pmids":["24782308"],"is_preprint":false},{"year":2014,"finding":"Silencing STXBP5 in vascular endothelial cells decreases tPA release, implicating STXBP5 in tPA exocytosis regulation","method":"siRNA knockdown, tPA release assay in endothelial cells","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 3 — single functional knockdown experiment, single lab","pmids":["24578379"],"is_preprint":false},{"year":2015,"finding":"Tomosyn knockdown at hippocampal mossy fiber-CA3 synapses impairs synaptic facilitation, PKA-induced potentiation, and LTP, indicating tomosyn is a key regulator of MF-CA3 synaptic plasticity and release probability","method":"Combined shRNA knockdown and optogenetic activation, electrophysiology in hippocampal slices","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — combined KD-optogenetic approach with defined electrophysiological readouts, single lab","pmids":["26166572"],"is_preprint":false},{"year":2015,"finding":"Tomosyn is phosphorylated by Akt at Ser-783; this phosphorylation inhibits tomosyn's interaction with syntaxin-4 and is required for insulin-stimulated GLUT4 surface expression","method":"In vitro kinase assay with Akt1/2, in vitro pull-down, intact cell phosphorylation with PI3K inhibitor, GLUT4 surface assay","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 1-2 — direct kinase assay plus interaction and functional assays, single lab","pmids":["25725259"],"is_preprint":false},{"year":2016,"finding":"Tomo1 regulates synaptic vesicle pool partitioning (RRP, TRP, resting pool) in hippocampal neurons in an activity-dependent manner via Cdk5 phosphorylation; Tomo1 interacts with Rab3A-GTP and synapsin 1a/b","method":"VGlut1-pHluorin fluorescence imaging, co-immunoprecipitation, KD and rescue in cultured neurons","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — imaging-based pool analysis combined with biochemical interaction studies, single lab","pmids":["27807164"],"is_preprint":false},{"year":2016,"finding":"Human SNP rs1039084 (N436S) in STXBP5, introduced by CRISPR/Cas9, causes lower plasma vWF levels, decreased thrombosis, and decreased platelet secretion in mice, establishing this variant as functionally causal","method":"CRISPR/Cas9 knock-in mouse model, vWF measurement, thrombosis assay, platelet activation","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 — precise in vivo genome editing with defined phenotype, single lab","pmids":["28062498"],"is_preprint":false},{"year":2017,"finding":"SUMOylation of tomosyn-1 at K298 is required for its inhibition of insulin exocytosis by binding syntaxin-1A; glucose-dependent de-SUMOylation of tomosyn releases syntaxin-1A; Ca2+-binding protein secretagogin interacts with tomosyn-1 and dissociates in response to Ca2+ to promote exocytosis","method":"Co-immunoprecipitation, site-directed mutagenesis, SUMO modification assay, insulin secretion assay in human beta cells","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with functional readout and novel interactor identification, single lab","pmids":["28325894"],"is_preprint":false},{"year":2017,"finding":"Tomosyn-1 is ubiquitinated and degraded by the proteasome via an interaction with the E3 ubiquitin ligase HRD1; HRD1 knockdown increases tomosyn-1 levels and dendritic spine density; overexpression of tomosyn-1 increases spine density independently of its C-terminal R-SNARE domain","method":"Immunoprecipitation of ubiquitinated Tomo-1, in vitro ubiquitination assay, HRD1 knockdown, spine density analysis in hippocampal neurons","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct in vitro ubiquitination with E3 ligase identified, functional spine analysis, single lab","pmids":["29269412"],"is_preprint":false},{"year":2017,"finding":"C. elegans UNC-18(P334A) gain-of-function and tom-1 null mutations synergistically suppress unc-13 mutant phenotypes; biochemically, Munc18-1(P335A) shows enhanced SNARE complex formation and partially bypasses Munc13-1 requirement, demonstrating that UNC-18 and Tomosyn act antagonistically downstream of UNC-13","method":"Genetic epistasis in C. elegans, liposome fusion assay, biochemical SNARE complex formation assay","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution plus genetic epistasis with multiple orthogonal approaches","pmids":["28821673"],"is_preprint":false},{"year":2018,"finding":"Tomosyn guides SNARE complex formation: NSF/α-SNAP releases syntaxin-1 from tomosyn arrest, enabling Munc18-1/syntaxin-1 complex formation; Munc13-1 then catalyzes transit of syntaxin-1 to the SNARE complex specifically with synaptobrevin-2 but not with tomosyn","method":"In vitro reconstitution of SNARE complex assembly, pull-down assays with purified proteins","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution with defined purified components, single lab","pmids":["29485200"],"is_preprint":false},{"year":2018,"finding":"Tomosyn-1 (STXBP5) inhibits IgE/FcεRI-stimulated mast cell degranulation; after activation, tomosyn-1 is phosphorylated on serine/threonine residues by PKCδ, dissociates from syntaxin-4, and associates with syntaxin-3; high IgE increases tomosyn-1 abundance as a counterregulatory mechanism","method":"FcεRI stimulation assay, co-immunoprecipitation, phosphorylation analysis, PKCδ inhibition","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical interaction and phosphorylation studies with functional degranulation readout, single lab","pmids":["29970602"],"is_preprint":false},{"year":2020,"finding":"Tomosyn inhibits basal and insulin-stimulated GLUT4 exocytosis in adipocytes; CRISPR-Cas9 double knockout of both tomosyn-encoding genes markedly elevates GLUT4 exocytosis; in reconstituted liposome fusion, tomosyn inhibits all SNARE complexes underlying GLUT4 exocytosis, and this inhibition is relieved by NSF/α-SNAP","method":"CRISPR-Cas9 double KO in adipocytes, reconstituted liposome fusion assay, GLUT4 surface assay","journal":"Traffic","confidence":"High","confidence_rationale":"Tier 1-2 — genetic KO combined with in vitro reconstitution, multiple orthogonal methods","pmids":["32851733"],"is_preprint":false},{"year":2020,"finding":"Tomosyn knockdown in neurons increases RhoA GTPase activity, causing impaired dendritic arborization, spine loss, decreased surface AMPA receptor expression, and reduced mEPSC frequency; the N-terminal WD40 domain mediates RhoA inhibition; ASD-associated variants in the WD40 domain show loss-of-function for RhoA regulation","method":"shRNA knockdown in mouse primary neurons, RhoA activity assay, surface AMPA receptor staining, electrophysiology, domain mutant rescue","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple cellular readouts with domain-specific rescue and disease variant analysis, single lab","pmids":["32133675"],"is_preprint":false},{"year":2014,"finding":"Tomosyn-1 interacts with the SUMO E3 ligase PIASγ through tomosyn's C-terminus and PIASγ's N-terminus; tomosyn-1 is preferentially modified by SUMO-2/3 isoform","method":"Yeast two-hybrid, reciprocal co-immunoprecipitation in HEK293T cells, SUMO modification assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by reciprocal co-IP, single lab","pmids":["24614299"],"is_preprint":false},{"year":2021,"finding":"In Drosophila, Tomosyn acts as a decoy SNARE that reduces SNARE complex formation to set tonic (low probability) vs phasic (high probability) release properties in distinct motoneuron subclasses; loss of Tomosyn disrupts presynaptic homeostatic potentiation at tonic synapses","method":"Drosophila genetic KO, electrophysiology comparing Ib vs Is motoneurons, homeostatic plasticity assay","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 — Drosophila ortholog, genetic loss-of-function with defined electrophysiological phenotypes, single lab","pmids":["34713802"],"is_preprint":false},{"year":2023,"finding":"Loss of tomosyns (Stxbp5 and Stxbp5l) in mouse neurons does not affect DCV fusion events but reduces intracellular DCV cargo levels (NPY, BDNF); rescue requires tomosyn but not its SNARE domain; tomosyns influence DCV biogenesis at the trans-Golgi network, decreasing TGN size and increasing DCV cargo flux speed","method":"Conditional double KO mouse, pHluorin-based single-vesicle DCV exocytosis assay, electron microscopy, live imaging of TGN","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with single-vesicle resolution assay and ultrastructural analysis, single lab","pmids":["37695731"],"is_preprint":false},{"year":2017,"finding":"Tomosyn-1 co-migrates with synapsin and neuropeptide Y markers for SVs and DCVs in live neurons despite lacking a membrane anchor; this vesicular association involves the WD40 and SNARE domains but is not abolished by blockade of synaptotagmin-1 or cognate SNARE interactions","method":"Live imaging in mouse hippocampal neurons, genetic blockade of known interactions","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — direct live imaging with genetic controls, single lab","pmids":["28746398"],"is_preprint":false},{"year":2023,"finding":"Synaptotagmin-9 (Syt9) colocalizes and binds with tomosyn-1 and syntaxin-1A to form an inhibitory Syt9-tomosyn-1-Stx1A complex; Syt9 knockdown reduces tomosyn-1 protein via proteasomal degradation, decreasing tomosyn-1 binding to Stx1A and increasing SNARE complex formation and insulin secretion; rescuing tomosyn-1 blocks Syt9-KD-mediated insulin secretion increase","method":"Co-immunoprecipitation, proteasome inhibitor treatment, rescue experiment, insulin secretion assay","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical complex identification with functional rescue validation, single lab","pmids":["37432648"],"is_preprint":false},{"year":2025,"finding":"Tomosyn-2 interacts with syntaxin-1A to inhibit insulin granule exocytosis by limiting SNARE complex assembly; tomosyn-2 KO mice show improved glucose clearance and enhanced biphasic insulin secretion; loss of tomosyn-2 also reduces beta-cell proliferation and suppresses Akt1 signaling","method":"Genetic KO mouse, co-immunoprecipitation, insulin secretion assay from isolated islets, transcriptomic analysis","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with multiple functional readouts and biochemical interaction, single lab","pmids":["42008692"],"is_preprint":false}],"current_model":"STXBP5 (tomosyn-1) is a soluble R-SNARE protein that inhibits exocytosis by (1) competing with synaptobrevin to form a non-fusogenic four-helical SNARE bundle with syntaxin and SNAP-25 via its C-terminal VAMP-like domain, and (2) oligomerizing SNARE complexes via its N-terminal WD-40 β-propeller domain; its inhibitory activity is regulated by post-translational modifications including PKA-mediated phosphorylation (which reduces syntaxin binding to promote release), ROCK-mediated phosphorylation of syntaxin (which increases tomosyn affinity), Akt-mediated phosphorylation at Ser-783 (relieving syntaxin-4 inhibition in GLUT4 exocytosis), SUMOylation at K298/K730 (required for inhibitory function), and HRD1/Hrd-1-mediated ubiquitin-proteasomal degradation; in the vasculature, STXBP5 interacts with syntaxin-4 to inhibit endothelial Weibel-Palade body exocytosis of vWF while promoting platelet granule secretion."},"narrative":{"teleology":[{"year":1998,"claim":"The discovery of tomosyn as a syntaxin-1-binding protein that displaces Munc18 and inhibits Ca²⁺-dependent exocytosis established the founding principle that a soluble factor can negatively regulate SNARE-mediated fusion.","evidence":"Co-immunoprecipitation, biochemical fractionation, and PC12 overexpression exocytosis assay","pmids":["9620695"],"confidence":"High","gaps":["Mechanism of inhibition (SNARE competition vs. other) not yet defined","No structural information on the tomosyn-syntaxin interaction","In vivo relevance not demonstrated"]},{"year":2003,"claim":"Demonstration that the C-terminal VAMP-like domain forms a stable four-helical SNARE bundle with syntaxin-1/SNAP-25 — competing directly with synaptobrevin — resolved the molecular mechanism of tomosyn's inhibitory activity and extended its scope to non-neuronal t-SNAREs (syntaxin-4/SNAP-23).","evidence":"In vitro reconstitution with recombinant proteins, CD spectroscopy, competition assays; parallel yeast two-hybrid and GLUT4 translocation assays in adipocytes","pmids":["12782620","12832401"],"confidence":"High","gaps":["Role of the large N-terminal WD40 domain unknown","No atomic-resolution structure yet"]},{"year":2004,"claim":"The crystal structure of the tomosyn SNARE complex at 2.0 Å, together with electrophysiological evidence that tomosyn inhibits the vesicle priming step without affecting docking, defined tomosyn as a decoy R-SNARE that traps syntaxin in a non-productive complex at the priming stage.","evidence":"X-ray crystallography and CD spectroscopy; capacitance measurements and amperometry in chromaffin cells","pmids":["15316007","14983051"],"confidence":"High","gaps":["Priming inhibition could involve additional WD40-dependent mechanisms","Regulation of tomosyn activity not addressed"]},{"year":2005,"claim":"Identification of PKA-mediated phosphorylation of tomosyn — which reduces syntaxin binding and enhances neurotransmitter release — and ROCK-mediated phosphorylation of syntaxin-1 — which increases tomosyn affinity — revealed that opposing kinase pathways bidirectionally tune tomosyn's inhibitory function.","evidence":"In vitro kinase assays, co-immunoprecipitation, electrophysiology in SCG neurons; ROCK kinase assays and growth cone imaging","pmids":["16186257","15240567"],"confidence":"High","gaps":["Specific phosphorylation sites on tomosyn for PKA not fully mapped","In vivo significance of ROCK-tomosyn axis in neurons not established"]},{"year":2006,"claim":"Genetic loss of the C. elegans ortholog tom-1 confirmed the conserved role of tomosyn as a negative regulator of vesicle priming in vivo, and epistasis with unc-13 placed tomosyn functionally downstream of the priming machinery.","evidence":"Electrophysiology, electron microscopy, and genetic epistasis in C. elegans","pmids":["16895441"],"confidence":"High","gaps":["Mammalian genetic loss-of-function not yet available","Whether the WD40 or SNARE domain mediates in vivo priming inhibition unclear"]},{"year":2007,"claim":"Structure–function dissection in chromaffin cells unexpectedly showed that the N-terminal WD40 domain, not the C-terminal SNARE domain, is the primary determinant of vesicle priming inhibition, challenging the SNARE-competition-only model.","evidence":"Domain deletion mutant overexpression with capacitance measurements in chromaffin cells","pmids":["17666050"],"confidence":"Medium","gaps":["Mechanism by which WD40 domain inhibits priming not identified","Apparent contradiction with SNARE-domain-centric model not resolved"]},{"year":2008,"claim":"The discovery that the WD40 domain catalyzes oligomerization of SNARE complexes provided a second, distinct inhibitory mechanism and reconciled the WD40-dependent priming inhibition with the SNARE-domain competition model as dual, complementary pathways.","evidence":"Microinjection into neurons, biochemical analysis of SNARE complex oligomerization, tomosyn-deficient mouse neurons","pmids":["18936251"],"confidence":"High","gaps":["Structural basis of WD40-mediated SNARE oligomerization unknown","Relative contributions of the two mechanisms in different cell types not quantified"]},{"year":2014,"claim":"A convergence of studies in 2014 established STXBP5's vascular function — inhibiting endothelial Weibel-Palade body exocytosis of vWF via syntaxin-4 while promoting platelet granule secretion via syntaxin-11/SNAP-23 — and demonstrated that the NTD recruits tomosyn to fusion sites while the CTD blocks v-SNARE pairing in reconstituted fusion.","evidence":"Stxbp5 KO mouse with thrombosis/bleeding phenotypes, siRNA in endothelial cells, co-IP with syntaxin-4 and syntaxin-11, reconstituted liposome fusion with purified full-length protein","pmids":["25244095","25244094","25063806"],"confidence":"High","gaps":["Why tomosyn promotes platelet secretion but inhibits endothelial secretion mechanistically unclear","Role of specific platelet SNARE isoforms not fully dissected"]},{"year":2014,"claim":"Identification of SUMOylation (by PIASγ, SUMO-2/3 at K730) and phosphorylation-dependent ubiquitin-proteasomal degradation (by Hrd-1 E3 ligase) of tomosyn established post-translational control of tomosyn protein levels and activity as a regulatory layer for insulin secretion.","evidence":"SUMO modification assays, yeast two-hybrid with PIASγ, mass spectrometry-mapped phosphosites, ubiquitination assays with Hrd-1","pmids":["24614299","25002582"],"confidence":"Medium","gaps":["In vivo significance of SUMOylation for insulin secretion not demonstrated in animal models","Whether Hrd-1 regulation applies to tomosyn-1 (not just tomosyn-2) was not shown at this point"]},{"year":2015,"claim":"Akt phosphorylation at Ser-783 was shown to relieve tomosyn's inhibition of syntaxin-4 interaction, linking insulin/PI3K signaling directly to derepression of GLUT4 exocytosis, while tomosyn knockdown at hippocampal mossy fiber synapses revealed a role in synaptic facilitation and LTP.","evidence":"In vitro kinase assay with Akt, GLUT4 surface assay; shRNA/optogenetic approach with slice electrophysiology","pmids":["25725259","26166572"],"confidence":"Medium","gaps":["In vivo validation of Akt-tomosyn axis in adipose tissue lacking","Mechanism by which tomosyn loss impairs facilitation (expected to enhance release) not fully explained"]},{"year":2017,"claim":"Multiple regulatory layers were defined: glucose-dependent de-SUMOylation at K298 releases syntaxin-1A in beta cells; secretagogin dissociates from tomosyn upon Ca²⁺ to promote exocytosis; HRD1 ubiquitinates tomosyn-1 to control dendritic spine density; and the human GWAS variant N436S was validated by CRISPR knock-in to reduce vWF and thrombosis.","evidence":"SUMO mutagenesis and insulin secretion in human beta cells; HRD1 in vitro ubiquitination and spine analysis in neurons; CRISPR/Cas9 knock-in mouse for N436S","pmids":["28325894","29269412","28062498"],"confidence":"Medium","gaps":["Structural basis for how N436S alters tomosyn function unknown","Role of secretagogin-tomosyn axis beyond beta cells not explored","Spine density effect appears SNARE-domain-independent — mechanism unclear"]},{"year":2018,"claim":"Reconstitution of the full SNARE assembly pathway showed that NSF/α-SNAP disassembles the tomosyn-syntaxin arrest, enabling Munc18-1 binding, after which Munc13-1 selectively channels syntaxin toward synaptobrevin rather than tomosyn — placing tomosyn within the ordered priming cascade.","evidence":"In vitro reconstitution with purified NSF, α-SNAP, Munc18-1, Munc13-1, and tomosyn","pmids":["29485200"],"confidence":"Medium","gaps":["Order of events not validated in intact synapses","Whether Munc13-1 selectivity applies to all tomosyn isoforms untested"]},{"year":2020,"claim":"CRISPR double KO of both tomosyn genes in adipocytes confirmed their non-redundant inhibition of all SNARE complexes underlying GLUT4 exocytosis, while neuronal studies revealed a SNARE-independent function: tomosyn's WD40 domain inhibits RhoA GTPase to maintain dendritic arborization and AMPA receptor surface expression, with ASD-associated WD40 variants showing loss of this function.","evidence":"CRISPR-Cas9 DKO adipocytes with reconstituted liposome fusion; shRNA in primary neurons with RhoA activity assay, surface AMPAR staining, and ASD variant rescue","pmids":["32851733","32133675"],"confidence":"High","gaps":["Mechanism by which WD40 domain inhibits RhoA (direct or indirect) not defined","ASD variant effects not validated in animal behavior"]},{"year":2023,"claim":"Conditional double KO of Stxbp5/Stxbp5l in mouse neurons unexpectedly revealed that tomosyns regulate dense-core vesicle biogenesis at the trans-Golgi network — decreasing DCV cargo levels without affecting fusion — a function independent of the SNARE domain, expanding tomosyn's role beyond fusion inhibition.","evidence":"Conditional DKO mouse, pHluorin single-vesicle DCV assay, electron microscopy, live TGN imaging","pmids":["37695731"],"confidence":"Medium","gaps":["Molecular mechanism of TGN cargo sorting regulation unknown","Which WD40-interacting partners at the TGN mediate this effect not identified","Relevance to synaptic vesicle cargo not tested"]},{"year":null,"claim":"Major open questions include: the structural basis for WD40-mediated SNARE oligomerization and RhoA inhibition; how tomosyn simultaneously promotes platelet secretion while inhibiting endothelial exocytosis; the mechanism underlying tomosyn's role in DCV biogenesis at the TGN; and whether ASD-associated WD40 variants cause behavioral phenotypes in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of full-length tomosyn or WD40 domain in complex with SNARE oligomers","Cell-type-specific functions (promote vs. inhibit secretion) mechanistically unexplained","DCV biogenesis pathway partners unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[1,2,16]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3,6,10,29]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[15]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,12]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[12,18]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[33]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[34]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,3,5,6,10,20]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,7,14,29]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[14,15,23]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,5,21,28]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[13,17,25,31]}],"complexes":["tomosyn-syntaxin-1-SNAP-25 ternary SNARE complex","tomosyn-syntaxin-4-SNAP-23 ternary SNARE complex"],"partners":["STX1A","SNAP25","STX4","SNAP23","STX11","SYNGR1","HRD1","SCGN"],"other_free_text":[]},"mechanistic_narrative":"STXBP5 (tomosyn-1) is a soluble R-SNARE protein that functions as a master negative regulator of SNARE-dependent exocytosis across diverse secretory cell types, including neurons, neuroendocrine cells, pancreatic beta cells, endothelial cells, platelets, and mast cells. It inhibits vesicle fusion through two mechanistically distinct domains: a C-terminal VAMP-like domain that forms a non-fusogenic four-helical SNARE bundle with syntaxin and SNAP-25, competitively excluding synaptobrevin from productive SNARE complexes [PMID:12782620, PMID:15316007], and an N-terminal WD40 β-propeller domain that oligomerizes SNARE complexes and is independently required for inhibition of vesicle priming [PMID:18936251, PMID:17666050]. Its inhibitory activity is dynamically regulated by PKA phosphorylation (relieving syntaxin binding to promote neurotransmitter release), Akt phosphorylation at Ser-783 (derepressing GLUT4 exocytosis), SUMOylation at K298/K730 (required for syntaxin sequestration in beta cells), and HRD1-mediated ubiquitin-proteasomal degradation [PMID:16186257, PMID:25725259, PMID:28325894, PMID:29269412]. In the vasculature, STXBP5 interacts with syntaxin-4 to inhibit endothelial Weibel-Palade body exocytosis of von Willebrand factor while promoting platelet granule secretion, and a human GWAS variant (N436S) has been functionally validated to lower plasma vWF and thrombosis in CRISPR knock-in mice [PMID:25244095, PMID:28062498]."},"prefetch_data":{"uniprot":{"accession":"Q5T5C0","full_name":"Syntaxin-binding protein 5","aliases":["Lethal(2) giant larvae protein homolog 3","Tomosyn-1"],"length_aa":1151,"mass_kda":127.6,"function":"Plays a regulatory role in calcium-dependent exocytosis and neurotransmitter release. Inhibits membrane fusion between transport vesicles and the plasma membrane. May modulate the assembly of trans-SNARE complexes between transport vesicles and the plasma membrane. Inhibits translocation of GLUT4 from intracellular vesicles to the plasma membrane. Competes with STXBP1 for STX1 binding (By similarity)","subcellular_location":"Cytoplasm; Cell membrane; Cytoplasmic vesicle membrane; Cytoplasmic vesicle, secretory vesicle, synaptic vesicle; Synapse","url":"https://www.uniprot.org/uniprotkb/Q5T5C0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/STXBP5","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/STXBP5","total_profiled":1310},"omim":[{"mim_id":"604586","title":"SYNTAXIN-BINDING PROTEIN 5; STXBP5","url":"https://www.omim.org/entry/604586"},{"mim_id":"600568","title":"NEUROLIGIN 1; NLGN1","url":"https://www.omim.org/entry/600568"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"parathyroid gland","ntpm":35.8}],"url":"https://www.proteinatlas.org/search/STXBP5"},"hgnc":{"alias_symbol":["tomosyn","LLGL3","tomosyn-1"],"prev_symbol":[]},"alphafold":{"accession":"Q5T5C0","domains":[{"cath_id":"2.130.10.10","chopping":"240-390","consensus_level":"medium","plddt":91.9604,"start":240,"end":390}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5T5C0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q5T5C0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q5T5C0-F1-predicted_aligned_error_v6.png","plddt_mean":78.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=STXBP5","jax_strain_url":"https://www.jax.org/strain/search?query=STXBP5"},"sequence":{"accession":"Q5T5C0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q5T5C0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q5T5C0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5T5C0"}},"corpus_meta":[{"pmid":"9620695","id":"PMC_9620695","title":"Tomosyn: a syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process.","date":"1998","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/9620695","citation_count":239,"is_preprint":false},{"pmid":"10402465","id":"PMC_10402465","title":"Yeast homologues of tomosyn and lethal giant larvae function in exocytosis and are associated with the plasma membrane SNARE, Sec9.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10402465","citation_count":184,"is_preprint":false},{"pmid":"16895441","id":"PMC_16895441","title":"Tomosyn inhibits synaptic vesicle priming in Caenorhabditis elegans.","date":"2006","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/16895441","citation_count":129,"is_preprint":false},{"pmid":"12782620","id":"PMC_12782620","title":"The R-SNARE motif of tomosyn forms SNARE core complexes with syntaxin 1 and SNAP-25 and down-regulates exocytosis.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12782620","citation_count":107,"is_preprint":false},{"pmid":"14983051","id":"PMC_14983051","title":"Tomosyn inhibits priming of large dense-core vesicles in a calcium-dependent manner.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14983051","citation_count":84,"is_preprint":false},{"pmid":"16186257","id":"PMC_16186257","title":"PKA-catalyzed phosphorylation of tomosyn and its implication in Ca2+-dependent exocytosis of neurotransmitter.","date":"2005","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16186257","citation_count":83,"is_preprint":false},{"pmid":"15316007","id":"PMC_15316007","title":"Structural basis for the inhibitory role of tomosyn in exocytosis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15316007","citation_count":80,"is_preprint":false},{"pmid":"23951547","id":"PMC_23951547","title":"UNC-13L, UNC-13S, and Tomosyn form a protein code for fast and slow neurotransmitter release in Caenorhabditis elegans.","date":"2013","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/23951547","citation_count":74,"is_preprint":false},{"pmid":"12832401","id":"PMC_12832401","title":"Tomosyn interacts with the t-SNAREs syntaxin4 and SNAP23 and plays a role in insulin-stimulated GLUT4 translocation.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12832401","citation_count":73,"is_preprint":false},{"pmid":"25244095","id":"PMC_25244095","title":"Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/25244095","citation_count":69,"is_preprint":false},{"pmid":"18936251","id":"PMC_18936251","title":"Dual inhibition of SNARE complex formation by tomosyn ensures controlled neurotransmitter release.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18936251","citation_count":65,"is_preprint":false},{"pmid":"15240567","id":"PMC_15240567","title":"Regulation of SNAREs by tomosyn and ROCK: implication in extension and retraction of neurites.","date":"2004","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15240567","citation_count":63,"is_preprint":false},{"pmid":"21998599","id":"PMC_21998599","title":"Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21998599","citation_count":62,"is_preprint":false},{"pmid":"16505218","id":"PMC_16505218","title":"Tomosyn is expressed in beta-cells and negatively regulates insulin exocytosis.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16505218","citation_count":53,"is_preprint":false},{"pmid":"31212131","id":"PMC_31212131","title":"LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31212131","citation_count":52,"is_preprint":false},{"pmid":"25832887","id":"PMC_25832887","title":"CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.","date":"2015","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/25832887","citation_count":51,"is_preprint":false},{"pmid":"17881523","id":"PMC_17881523","title":"Tomosyn negatively regulates CAPS-dependent peptide release at Caenorhabditis elegans synapses.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17881523","citation_count":47,"is_preprint":false},{"pmid":"25244094","id":"PMC_25244094","title":"Platelet secretion and hemostasis require syntaxin-binding protein STXBP5.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/25244094","citation_count":46,"is_preprint":false},{"pmid":"16787939","id":"PMC_16787939","title":"Tomosyn-1 is involved in a post-docking event required for pancreatic beta-cell exocytosis.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16787939","citation_count":46,"is_preprint":false},{"pmid":"19307030","id":"PMC_19307030","title":"Friends and foes in synaptic transmission: the role of tomosyn in vesicle priming.","date":"2009","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/19307030","citation_count":43,"is_preprint":false},{"pmid":"15659226","id":"PMC_15659226","title":"Two distinct genes drive expression of seven tomosyn isoforms in the mammalian brain, sharing a conserved structure with a unique variable domain.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15659226","citation_count":40,"is_preprint":false},{"pmid":"21330375","id":"PMC_21330375","title":"Structural and functional analysis of tomosyn identifies domains important in exocytotic regulation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21330375","citation_count":39,"is_preprint":false},{"pmid":"16103915","id":"PMC_16103915","title":"Using microarrays to facilitate positional cloning: identification of tomosyn as an inhibitor of neurosecretion.","date":"2005","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16103915","citation_count":38,"is_preprint":false},{"pmid":"24578379","id":"PMC_24578379","title":"Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.","date":"2014","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24578379","citation_count":37,"is_preprint":false},{"pmid":"17666050","id":"PMC_17666050","title":"Multiple functional domains are involved in tomosyn regulation of exocytosis.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17666050","citation_count":36,"is_preprint":false},{"pmid":"28325894","id":"PMC_28325894","title":"SUMOylation and calcium control syntaxin-1A and secretagogin sequestration by tomosyn to regulate insulin exocytosis in human ß cells.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28325894","citation_count":35,"is_preprint":false},{"pmid":"17545156","id":"PMC_17545156","title":"Receptor-mediated regulation of tomosyn-syntaxin 1A interactions in bovine adrenal chromaffin cells.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17545156","citation_count":34,"is_preprint":false},{"pmid":"10066450","id":"PMC_10066450","title":"Three splicing variants of tomosyn and identification of their syntaxin-binding region.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10066450","citation_count":34,"is_preprint":false},{"pmid":"28821673","id":"PMC_28821673","title":"UNC-18 and Tomosyn Antagonistically Control Synaptic Vesicle Priming Downstream of UNC-13 in Caenorhabditis elegans.","date":"2017","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28821673","citation_count":33,"is_preprint":false},{"pmid":"17627987","id":"PMC_17627987","title":"Tomosyn negatively regulates both synaptic transmitter and neuropeptide release at the C. elegans neuromuscular junction.","date":"2007","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17627987","citation_count":31,"is_preprint":false},{"pmid":"22042858","id":"PMC_22042858","title":"Tomosyn-dependent regulation of synaptic transmission is required for a late phase of associative odor memory.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22042858","citation_count":30,"is_preprint":false},{"pmid":"24782308","id":"PMC_24782308","title":"Differential interaction of tomosyn with syntaxin and SNAP25 depends on domains in the WD40 β-propeller core and determines its inhibitory activity.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24782308","citation_count":27,"is_preprint":false},{"pmid":"30881044","id":"PMC_30881044","title":"Long noncoding RNA STXBP5-AS1 inhibits cell proliferation, migration, and invasion through inhibiting the PI3K/AKT signaling pathway in gastric cancer cells.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30881044","citation_count":27,"is_preprint":false},{"pmid":"27807164","id":"PMC_27807164","title":"Dynamic Partitioning of Synaptic Vesicle Pools by the SNARE-Binding Protein Tomosyn.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27807164","citation_count":26,"is_preprint":false},{"pmid":"26166572","id":"PMC_26166572","title":"A Combined Optogenetic-Knockdown Strategy Reveals a Major Role of Tomosyn in Mossy Fiber Synaptic Plasticity.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26166572","citation_count":25,"is_preprint":false},{"pmid":"25063806","id":"PMC_25063806","title":"The N- and C-terminal domains of tomosyn play distinct roles in soluble N-ethylmaleimide-sensitive factor attachment protein receptor binding and fusion regulation.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25063806","citation_count":24,"is_preprint":false},{"pmid":"28062498","id":"PMC_28062498","title":"Novel Thrombotic Function of a Human SNP in STXBP5 Revealed by CRISPR/Cas9 Gene Editing in Mice.","date":"2016","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28062498","citation_count":23,"is_preprint":false},{"pmid":"25002582","id":"PMC_25002582","title":"Phosphorylation and degradation of tomosyn-2 de-represses insulin secretion.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25002582","citation_count":22,"is_preprint":false},{"pmid":"31700260","id":"PMC_31700260","title":"Ginsenoside Rg3 and Korean Red Ginseng extract epigenetically regulate the tumor-related long noncoding RNAs RFX3-AS1 and STXBP5-AS1.","date":"2019","source":"Journal of ginseng research","url":"https://pubmed.ncbi.nlm.nih.gov/31700260","citation_count":22,"is_preprint":false},{"pmid":"21191478","id":"PMC_21191478","title":"Tomosyn expression pattern in the mouse hippocampus suggests both presynaptic and postsynaptic functions.","date":"2010","source":"Frontiers in neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/21191478","citation_count":22,"is_preprint":false},{"pmid":"34764730","id":"PMC_34764730","title":"Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation.","date":"2021","source":"Journal of ginseng research","url":"https://pubmed.ncbi.nlm.nih.gov/34764730","citation_count":20,"is_preprint":false},{"pmid":"34713802","id":"PMC_34713802","title":"The decoy SNARE Tomosyn sets tonic versus phasic release properties and is required for homeostatic synaptic plasticity.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34713802","citation_count":20,"is_preprint":false},{"pmid":"24744148","id":"PMC_24744148","title":"Tomosyn-2 is required for normal motor performance in mice and sustains neurotransmission at motor endplates.","date":"2014","source":"Brain structure & function","url":"https://pubmed.ncbi.nlm.nih.gov/24744148","citation_count":20,"is_preprint":false},{"pmid":"29485200","id":"PMC_29485200","title":"Tomosyn guides SNARE complex formation in coordination with Munc18 and Munc13.","date":"2018","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/29485200","citation_count":16,"is_preprint":false},{"pmid":"29970602","id":"PMC_29970602","title":"Tomosyn functions as a PKCδ-regulated fusion clamp in mast cell degranulation.","date":"2018","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/29970602","citation_count":16,"is_preprint":false},{"pmid":"31530628","id":"PMC_31530628","title":"Overexpressed Tomosyn Binds Syntaxins and Blocks Secretion during Pollen Development.","date":"2019","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31530628","citation_count":16,"is_preprint":false},{"pmid":"30450569","id":"PMC_30450569","title":"Long noncoding RNA STXBP5-AS1 inhibits cell proliferation, migration, and invasion via preventing the PI3K/AKT against STXBP5 expression in non-small-cell lung carcinoma.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30450569","citation_count":15,"is_preprint":false},{"pmid":"25725259","id":"PMC_25725259","title":"Tomosyn is a novel Akt substrate mediating insulin-dependent GLUT4 exocytosis.","date":"2015","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25725259","citation_count":14,"is_preprint":false},{"pmid":"32133675","id":"PMC_32133675","title":"Tomosyn regulates the small RhoA GTPase to control the dendritic stability of neurons and the surface expression of AMPA receptors.","date":"2020","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/32133675","citation_count":13,"is_preprint":false},{"pmid":"32851733","id":"PMC_32851733","title":"Genetic evidence for an inhibitory role of tomosyn in insulin-stimulated GLUT4 exocytosis.","date":"2020","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/32851733","citation_count":13,"is_preprint":false},{"pmid":"22022557","id":"PMC_22022557","title":"In vivo analysis of conserved C. elegans tomosyn domains.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22022557","citation_count":13,"is_preprint":false},{"pmid":"28746398","id":"PMC_28746398","title":"Tomosyn associates with secretory vesicles in neurons through its N- and C-terminal domains.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28746398","citation_count":12,"is_preprint":false},{"pmid":"25404740","id":"PMC_25404740","title":"In vitro reconstitution of Rab GTPase-dependent vesicle clustering by the yeast lethal giant larvae/tomosyn homolog, Sro7.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25404740","citation_count":12,"is_preprint":false},{"pmid":"29269412","id":"PMC_29269412","title":"The ubiquitin-proteasome system functionally links neuronal Tomosyn-1 to dendritic morphology.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29269412","citation_count":10,"is_preprint":false},{"pmid":"33965377","id":"PMC_33965377","title":"Aberrant hypermethylation induced downregulation of antisense lncRNA STXBP5-AS1 and its sense gene STXBP5 correlate with tumorigenesis of glioma.","date":"2021","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33965377","citation_count":10,"is_preprint":false},{"pmid":"24614299","id":"PMC_24614299","title":"Tomosyn interacts with the SUMO E3 ligase PIASγ.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24614299","citation_count":10,"is_preprint":false},{"pmid":"26202462","id":"PMC_26202462","title":"Structural basis for recognition of the Sec4 Rab GTPase by its effector, the Lgl/tomosyn homologue, Sro7.","date":"2015","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/26202462","citation_count":10,"is_preprint":false},{"pmid":"29668350","id":"PMC_29668350","title":"The tomosyn homologue, Sro7, is a direct effector of the Rab GTPase, Sec4, in post-Golgi vesicle tethering.","date":"2018","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/29668350","citation_count":10,"is_preprint":false},{"pmid":"28948088","id":"PMC_28948088","title":"Linking kindling to increased glutamate release in the dentate gyrus of the hippocampus through the STXBP5/tomosyn-1 gene.","date":"2017","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/28948088","citation_count":9,"is_preprint":false},{"pmid":"29972863","id":"PMC_29972863","title":"Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients.","date":"2018","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/29972863","citation_count":8,"is_preprint":false},{"pmid":"12792798","id":"PMC_12792798","title":"WD-40 repeat containing rat lethal giant larvae recessive oncogene, but not m-tomosyn, restores the salt sensitivity in Saccharomyces cerevisiae.","date":"2003","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12792798","citation_count":7,"is_preprint":false},{"pmid":"37695731","id":"PMC_37695731","title":"Tomosyn affects dense core vesicle composition but not exocytosis in mammalian neurons.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37695731","citation_count":6,"is_preprint":false},{"pmid":"30659475","id":"PMC_30659475","title":"A Potential Role for the STXBP5-AS1 Gene in Adult ADHD Symptoms.","date":"2019","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30659475","citation_count":5,"is_preprint":false},{"pmid":"37014062","id":"PMC_37014062","title":"TOM-1/tomosyn acts with the UNC-6/netrin receptor UNC-5 to inhibit growth cone protrusion in Caenorhabditis elegans.","date":"2023","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37014062","citation_count":4,"is_preprint":false},{"pmid":"27732637","id":"PMC_27732637","title":"Tomosyn Negatively Regulates Arginine Vasopressin Secretion in Embryonic Stem Cell-Derived Neurons.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27732637","citation_count":4,"is_preprint":false},{"pmid":"39379476","id":"PMC_39379476","title":"The syntaxin-binding protein STXBP5 regulates progerin expression.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39379476","citation_count":3,"is_preprint":false},{"pmid":"37432648","id":"PMC_37432648","title":"Genetic ablation of synaptotagmin-9 alters tomosyn-1 function to increase insulin secretion from pancreatic β-cells improving glucose clearance.","date":"2023","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/37432648","citation_count":2,"is_preprint":false},{"pmid":"31149145","id":"PMC_31149145","title":"RESISTIN INHIBITS GLUCOSE-STIMULATED INSULIN SECRETION THROUGH MIR-494 BY TARGET ON STXBP5.","date":"2017","source":"Acta endocrinologica (Bucharest, Romania : 2005)","url":"https://pubmed.ncbi.nlm.nih.gov/31149145","citation_count":2,"is_preprint":false},{"pmid":"37615869","id":"PMC_37615869","title":"The Role of Tomosyn in the Regulation of Neurotransmitter Release.","date":"2023","source":"Advances in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/37615869","citation_count":0,"is_preprint":false},{"pmid":"40475581","id":"PMC_40475581","title":"Tomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Homeostasis.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40475581","citation_count":0,"is_preprint":false},{"pmid":"42008692","id":"PMC_42008692","title":"Tomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Homeostasis.","date":"2026","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/42008692","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":36422,"output_tokens":8025,"usd":0.114821},"stage2":{"model":"claude-opus-4-6","input_tokens":11870,"output_tokens":4198,"usd":0.24645},"total_usd":0.361271,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Tomosyn (STXBP5) binds syntaxin-1, dissociates Munc18 from syntaxin-1, and forms a novel 10S complex with syntaxin-1, SNAP-25, and synaptotagmin; high-level expression reduces Ca2+-dependent exocytosis in PC12 cells\",\n      \"method\": \"Co-immunoprecipitation, biochemical fractionation, PC12 cell overexpression assay\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — original discovery paper with multiple orthogonal biochemical methods, highly cited, replicated by subsequent work\",\n      \"pmids\": [\"9620695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The C-terminal R-SNARE motif of tomosyn forms a stable four-helical SNARE core complex with syntaxin-1 and SNAP-25, competing with synaptobrevin for SNARE complex formation and inhibiting exocytosis; complexes are disassembled by NSF/α-SNAP\",\n      \"method\": \"In vitro reconstitution with recombinant proteins, CD spectroscopy, inside-out plasma membrane sheets competition assay, PC12 cell exocytosis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with multiple orthogonal methods including structural characterization, replicated\",\n      \"pmids\": [\"12782620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Crystal structure of the tomosyn SNARE core complex at 2.0-Å resolution reveals a four-helical bundle nearly identical to the synaptobrevin SNARE complex; synaptobrevin cannot displace the tomosyn helix and vice versa, indicating both represent stable end products\",\n      \"method\": \"X-ray crystallography, CD spectroscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional validation\",\n      \"pmids\": [\"15316007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Tomosyn inhibits the priming step of large dense-core vesicle exocytosis in chromaffin cells in a calcium-dependent manner, reducing fusion-competent vesicle number without affecting docked vesicle number or single-vesicle fusion kinetics\",\n      \"method\": \"Morphological analysis, capacitance measurements, amperometry, chromaffin cell overexpression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal physiological methods, replicated concept across labs\",\n      \"pmids\": [\"14983051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ROCK (activated by Rho GTPase) phosphorylates syntaxin-1, increasing its affinity for tomosyn and forming a stable tomosyn-syntaxin complex that inhibits SNARE complex formation; this localizes tomosyn to growth cone palms to regulate neurite extension and retraction\",\n      \"method\": \"Biochemical interaction assays, kinase assays, confocal microscopy of growth cones\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical evidence for phosphorylation-dependent interaction, single lab\",\n      \"pmids\": [\"15240567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PKA directly phosphorylates tomosyn, reducing its interaction with syntaxin-1 and enhancing SNARE complex formation; this increases the readily releasable pool and neurotransmitter release in SCG neurons, mediating PACAP-induced synaptic facilitation\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, electrophysiology in cultured SCG neurons\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct phosphorylation assay combined with electrophysiology and interaction studies\",\n      \"pmids\": [\"16186257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"C. elegans TOM-1 (tomosyn ortholog) negatively regulates synaptic vesicle priming at the NMJ; tom-1 mutants show increased plasma membrane-contacting vesicles and enhanced hyperosmotic responses; tom-1 unc-13 double mutants partially suppress unc-13 priming defects\",\n      \"method\": \"Electrophysiology, electron microscopy ultrastructure, hyperosmotic response assay, genetic epistasis\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including epistasis, replicated concept\",\n      \"pmids\": [\"16895441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Tomosyn-1 is expressed in pancreatic beta-cells, co-immunoprecipitates with syntaxin-1, and negatively regulates insulin exocytosis; siRNA knockdown increases exocytosis while overexpression decreases it\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, overexpression, exocytosis measurement\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP and functional KD/OE, single lab\",\n      \"pmids\": [\"16505218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Tomosyn-1 in pancreatic beta-cells is involved in a post-docking event required for exocytosis; silencing tomosyn-1 does not affect docked granule number but reduces stimulus-induced exocytosis; the SNARE-like domain forms a complex with syntaxin-1 and SNAP-25 with weaker binding forces than VAMP2\",\n      \"method\": \"Atomic force microscopy, RNA interference, electron microscopy, exocytosis assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — AFM binding force measurement combined with functional RNAi, single lab\",\n      \"pmids\": [\"16787939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Tomosyn interacts with t-SNAREs syntaxin-4 and SNAP-23 through its VAMP-2-like domain, forming a ternary complex competitively inhibited by VAMP-2; overexpression in adipocytes inhibits insulin-stimulated GLUT4 translocation to the plasma membrane\",\n      \"method\": \"Yeast two-hybrid, in vitro binding, GLUT4-GFP translocation assay in 3T3-L1 adipocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple binding assays plus cellular functional assay, single lab\",\n      \"pmids\": [\"12832401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Tomosyn inhibits SNARE complex formation and neurotransmitter release through dual mechanisms: (1) C-terminal VAMP-like domain sequesters syntaxin-1; (2) N-terminal WD-40 repeat domain catalyzes oligomerization of SNARE complexes; microinjection of the WD-40 domain into neurons prevented stimulated acetylcholine release\",\n      \"method\": \"Microinjection, biochemical analysis of SNARE complex oligomerization, tomosyn-deficient mouse neurons\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct neuronal microinjection combined with biochemical analysis and genetic model\",\n      \"pmids\": [\"18936251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Tomosyn WD-40 domain integrity (not the SNARE domain) is required for inhibition of vesicle priming; a truncation lacking the entire SNARE domain still inhibits exocytosis, while N-terminal truncations abolish inhibition despite retaining syntaxin binding\",\n      \"method\": \"Domain deletion mutant overexpression in chromaffin cells, capacitance measurements\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — structure-function analysis with multiple mutants and functional readout, single lab\",\n      \"pmids\": [\"17666050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Secretagogue stimulation causes rapid translocation of tomosyn from cytosol to plasma membrane and increases tomosyn-syntaxin-1A interaction; this is mediated by RhoA/ROCK signaling, as ROCK inhibition blocks the secretagogue-induced tomosyn-syntaxin interaction\",\n      \"method\": \"Live-cell imaging, FRAP, co-immunoprecipitation, pharmacological inhibition in chromaffin cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — live imaging and biochemistry combined, single lab\",\n      \"pmids\": [\"17545156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"m-tomosyn-1 is a substrate for SUMO-2/3 conjugation; mutation of the SUMO target site (Lys-730) enhances tomosyn-1 inhibition of secretion without altering interaction with syntaxin-1A; loop domains 1 and 3 of the β-propeller core are required for inhibitory activity independent of SNARE pairing\",\n      \"method\": \"Site-directed mutagenesis, SUMO conjugation assay, secretion assay in PC12 cells, homology modeling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional secretion readout, single lab\",\n      \"pmids\": [\"21330375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"STXBP5 is expressed in human endothelial cells, colocalizes and interacts with syntaxin-4; STXBP5 knockdown increases vWF and P-selectin exocytosis; Stxbp5 KO mice have elevated plasma vWF, increased platelet-endothelial interactions, but also impaired platelet secretion and hemostasis\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, Stxbp5 KO mouse model, tail bleeding, thrombosis assay\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including KO mouse with defined phenotypes\",\n      \"pmids\": [\"25244095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"STXBP5 (tomosyn-1) in platelets interacts with syntaxin-11/SNAP-23 heterodimers and the platelet cytoskeleton; Stxbp5 KO mice show defective secretion from all three granule types and altered granule cargo levels, demonstrating a role in platelet granule cargo packaging and secretion\",\n      \"method\": \"Mass spectrometry identification, co-immunoprecipitation, fractionation, Stxbp5 KO mouse, lumi-aggregometry, FACS\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS identification plus KO mouse with multiple functional readouts\",\n      \"pmids\": [\"25244094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The C-terminal domain (CTD) of tomosyn mediates inhibition of SNARE-dependent membrane fusion by recognizing the t-SNARE complex and preventing v-SNARE pairing; the N-terminal domain (NTD) is required for binding to syntaxin monomer and recruitment to fusion sites; tomosyn inhibition is dominant over Munc18 stimulatory activity\",\n      \"method\": \"In vitro reconstituted liposome fusion assay, purified full-length and truncated proteins, binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified full-length protein and defined domain dissection\",\n      \"pmids\": [\"25063806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Tomosyn-2 is phosphorylated in response to high glucose, phorbol esters, and cAMP analogs; phosphomimetic mutants show enhanced proteasomal degradation and reduced inhibition of insulin secretion; Hrd-1 E3 ubiquitin ligase binds tomosyn-2 and promotes its ubiquitination and degradation\",\n      \"method\": \"32P labeling, mass spectrometry, site-directed mutagenesis, proteomic screen, ubiquitination assay, shRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — phosphorylation mapped by MS, mutagenesis, E3 ligase identified with functional validation\",\n      \"pmids\": [\"25002582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Tomosyn is organized in small clusters adjacent to syntaxin clusters on the plasma membrane; tomosyn inhibition of exocytosis is mediated through tomosyn-syntaxin-SNAP25 ternary complexes rather than tomosyn-syntaxin binary complexes; WD-40 core residues 537-578 and 897-917 are required for SNAP25 binding\",\n      \"method\": \"dSTORM super-resolution microscopy, deletion mutant analysis, FRAP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — super-resolution imaging combined with functional mutagenesis, single lab\",\n      \"pmids\": [\"24782308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Silencing STXBP5 in vascular endothelial cells decreases tPA release, implicating STXBP5 in tPA exocytosis regulation\",\n      \"method\": \"siRNA knockdown, tPA release assay in endothelial cells\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single functional knockdown experiment, single lab\",\n      \"pmids\": [\"24578379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Tomosyn knockdown at hippocampal mossy fiber-CA3 synapses impairs synaptic facilitation, PKA-induced potentiation, and LTP, indicating tomosyn is a key regulator of MF-CA3 synaptic plasticity and release probability\",\n      \"method\": \"Combined shRNA knockdown and optogenetic activation, electrophysiology in hippocampal slices\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — combined KD-optogenetic approach with defined electrophysiological readouts, single lab\",\n      \"pmids\": [\"26166572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Tomosyn is phosphorylated by Akt at Ser-783; this phosphorylation inhibits tomosyn's interaction with syntaxin-4 and is required for insulin-stimulated GLUT4 surface expression\",\n      \"method\": \"In vitro kinase assay with Akt1/2, in vitro pull-down, intact cell phosphorylation with PI3K inhibitor, GLUT4 surface assay\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — direct kinase assay plus interaction and functional assays, single lab\",\n      \"pmids\": [\"25725259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Tomo1 regulates synaptic vesicle pool partitioning (RRP, TRP, resting pool) in hippocampal neurons in an activity-dependent manner via Cdk5 phosphorylation; Tomo1 interacts with Rab3A-GTP and synapsin 1a/b\",\n      \"method\": \"VGlut1-pHluorin fluorescence imaging, co-immunoprecipitation, KD and rescue in cultured neurons\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — imaging-based pool analysis combined with biochemical interaction studies, single lab\",\n      \"pmids\": [\"27807164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Human SNP rs1039084 (N436S) in STXBP5, introduced by CRISPR/Cas9, causes lower plasma vWF levels, decreased thrombosis, and decreased platelet secretion in mice, establishing this variant as functionally causal\",\n      \"method\": \"CRISPR/Cas9 knock-in mouse model, vWF measurement, thrombosis assay, platelet activation\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — precise in vivo genome editing with defined phenotype, single lab\",\n      \"pmids\": [\"28062498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SUMOylation of tomosyn-1 at K298 is required for its inhibition of insulin exocytosis by binding syntaxin-1A; glucose-dependent de-SUMOylation of tomosyn releases syntaxin-1A; Ca2+-binding protein secretagogin interacts with tomosyn-1 and dissociates in response to Ca2+ to promote exocytosis\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis, SUMO modification assay, insulin secretion assay in human beta cells\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional readout and novel interactor identification, single lab\",\n      \"pmids\": [\"28325894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Tomosyn-1 is ubiquitinated and degraded by the proteasome via an interaction with the E3 ubiquitin ligase HRD1; HRD1 knockdown increases tomosyn-1 levels and dendritic spine density; overexpression of tomosyn-1 increases spine density independently of its C-terminal R-SNARE domain\",\n      \"method\": \"Immunoprecipitation of ubiquitinated Tomo-1, in vitro ubiquitination assay, HRD1 knockdown, spine density analysis in hippocampal neurons\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vitro ubiquitination with E3 ligase identified, functional spine analysis, single lab\",\n      \"pmids\": [\"29269412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"C. elegans UNC-18(P334A) gain-of-function and tom-1 null mutations synergistically suppress unc-13 mutant phenotypes; biochemically, Munc18-1(P335A) shows enhanced SNARE complex formation and partially bypasses Munc13-1 requirement, demonstrating that UNC-18 and Tomosyn act antagonistically downstream of UNC-13\",\n      \"method\": \"Genetic epistasis in C. elegans, liposome fusion assay, biochemical SNARE complex formation assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution plus genetic epistasis with multiple orthogonal approaches\",\n      \"pmids\": [\"28821673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Tomosyn guides SNARE complex formation: NSF/α-SNAP releases syntaxin-1 from tomosyn arrest, enabling Munc18-1/syntaxin-1 complex formation; Munc13-1 then catalyzes transit of syntaxin-1 to the SNARE complex specifically with synaptobrevin-2 but not with tomosyn\",\n      \"method\": \"In vitro reconstitution of SNARE complex assembly, pull-down assays with purified proteins\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with defined purified components, single lab\",\n      \"pmids\": [\"29485200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Tomosyn-1 (STXBP5) inhibits IgE/FcεRI-stimulated mast cell degranulation; after activation, tomosyn-1 is phosphorylated on serine/threonine residues by PKCδ, dissociates from syntaxin-4, and associates with syntaxin-3; high IgE increases tomosyn-1 abundance as a counterregulatory mechanism\",\n      \"method\": \"FcεRI stimulation assay, co-immunoprecipitation, phosphorylation analysis, PKCδ inhibition\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical interaction and phosphorylation studies with functional degranulation readout, single lab\",\n      \"pmids\": [\"29970602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Tomosyn inhibits basal and insulin-stimulated GLUT4 exocytosis in adipocytes; CRISPR-Cas9 double knockout of both tomosyn-encoding genes markedly elevates GLUT4 exocytosis; in reconstituted liposome fusion, tomosyn inhibits all SNARE complexes underlying GLUT4 exocytosis, and this inhibition is relieved by NSF/α-SNAP\",\n      \"method\": \"CRISPR-Cas9 double KO in adipocytes, reconstituted liposome fusion assay, GLUT4 surface assay\",\n      \"journal\": \"Traffic\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO combined with in vitro reconstitution, multiple orthogonal methods\",\n      \"pmids\": [\"32851733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Tomosyn knockdown in neurons increases RhoA GTPase activity, causing impaired dendritic arborization, spine loss, decreased surface AMPA receptor expression, and reduced mEPSC frequency; the N-terminal WD40 domain mediates RhoA inhibition; ASD-associated variants in the WD40 domain show loss-of-function for RhoA regulation\",\n      \"method\": \"shRNA knockdown in mouse primary neurons, RhoA activity assay, surface AMPA receptor staining, electrophysiology, domain mutant rescue\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple cellular readouts with domain-specific rescue and disease variant analysis, single lab\",\n      \"pmids\": [\"32133675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Tomosyn-1 interacts with the SUMO E3 ligase PIASγ through tomosyn's C-terminus and PIASγ's N-terminus; tomosyn-1 is preferentially modified by SUMO-2/3 isoform\",\n      \"method\": \"Yeast two-hybrid, reciprocal co-immunoprecipitation in HEK293T cells, SUMO modification assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by reciprocal co-IP, single lab\",\n      \"pmids\": [\"24614299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In Drosophila, Tomosyn acts as a decoy SNARE that reduces SNARE complex formation to set tonic (low probability) vs phasic (high probability) release properties in distinct motoneuron subclasses; loss of Tomosyn disrupts presynaptic homeostatic potentiation at tonic synapses\",\n      \"method\": \"Drosophila genetic KO, electrophysiology comparing Ib vs Is motoneurons, homeostatic plasticity assay\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Drosophila ortholog, genetic loss-of-function with defined electrophysiological phenotypes, single lab\",\n      \"pmids\": [\"34713802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Loss of tomosyns (Stxbp5 and Stxbp5l) in mouse neurons does not affect DCV fusion events but reduces intracellular DCV cargo levels (NPY, BDNF); rescue requires tomosyn but not its SNARE domain; tomosyns influence DCV biogenesis at the trans-Golgi network, decreasing TGN size and increasing DCV cargo flux speed\",\n      \"method\": \"Conditional double KO mouse, pHluorin-based single-vesicle DCV exocytosis assay, electron microscopy, live imaging of TGN\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with single-vesicle resolution assay and ultrastructural analysis, single lab\",\n      \"pmids\": [\"37695731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Tomosyn-1 co-migrates with synapsin and neuropeptide Y markers for SVs and DCVs in live neurons despite lacking a membrane anchor; this vesicular association involves the WD40 and SNARE domains but is not abolished by blockade of synaptotagmin-1 or cognate SNARE interactions\",\n      \"method\": \"Live imaging in mouse hippocampal neurons, genetic blockade of known interactions\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct live imaging with genetic controls, single lab\",\n      \"pmids\": [\"28746398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Synaptotagmin-9 (Syt9) colocalizes and binds with tomosyn-1 and syntaxin-1A to form an inhibitory Syt9-tomosyn-1-Stx1A complex; Syt9 knockdown reduces tomosyn-1 protein via proteasomal degradation, decreasing tomosyn-1 binding to Stx1A and increasing SNARE complex formation and insulin secretion; rescuing tomosyn-1 blocks Syt9-KD-mediated insulin secretion increase\",\n      \"method\": \"Co-immunoprecipitation, proteasome inhibitor treatment, rescue experiment, insulin secretion assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical complex identification with functional rescue validation, single lab\",\n      \"pmids\": [\"37432648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Tomosyn-2 interacts with syntaxin-1A to inhibit insulin granule exocytosis by limiting SNARE complex assembly; tomosyn-2 KO mice show improved glucose clearance and enhanced biphasic insulin secretion; loss of tomosyn-2 also reduces beta-cell proliferation and suppresses Akt1 signaling\",\n      \"method\": \"Genetic KO mouse, co-immunoprecipitation, insulin secretion assay from isolated islets, transcriptomic analysis\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with multiple functional readouts and biochemical interaction, single lab\",\n      \"pmids\": [\"42008692\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"STXBP5 (tomosyn-1) is a soluble R-SNARE protein that inhibits exocytosis by (1) competing with synaptobrevin to form a non-fusogenic four-helical SNARE bundle with syntaxin and SNAP-25 via its C-terminal VAMP-like domain, and (2) oligomerizing SNARE complexes via its N-terminal WD-40 β-propeller domain; its inhibitory activity is regulated by post-translational modifications including PKA-mediated phosphorylation (which reduces syntaxin binding to promote release), ROCK-mediated phosphorylation of syntaxin (which increases tomosyn affinity), Akt-mediated phosphorylation at Ser-783 (relieving syntaxin-4 inhibition in GLUT4 exocytosis), SUMOylation at K298/K730 (required for inhibitory function), and HRD1/Hrd-1-mediated ubiquitin-proteasomal degradation; in the vasculature, STXBP5 interacts with syntaxin-4 to inhibit endothelial Weibel-Palade body exocytosis of vWF while promoting platelet granule secretion.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"STXBP5 (tomosyn-1) is a soluble R-SNARE protein that functions as a master negative regulator of SNARE-dependent exocytosis across diverse secretory cell types, including neurons, neuroendocrine cells, pancreatic beta cells, endothelial cells, platelets, and mast cells. It inhibits vesicle fusion through two mechanistically distinct domains: a C-terminal VAMP-like domain that forms a non-fusogenic four-helical SNARE bundle with syntaxin and SNAP-25, competitively excluding synaptobrevin from productive SNARE complexes [PMID:12782620, PMID:15316007], and an N-terminal WD40 β-propeller domain that oligomerizes SNARE complexes and is independently required for inhibition of vesicle priming [PMID:18936251, PMID:17666050]. Its inhibitory activity is dynamically regulated by PKA phosphorylation (relieving syntaxin binding to promote neurotransmitter release), Akt phosphorylation at Ser-783 (derepressing GLUT4 exocytosis), SUMOylation at K298/K730 (required for syntaxin sequestration in beta cells), and HRD1-mediated ubiquitin-proteasomal degradation [PMID:16186257, PMID:25725259, PMID:28325894, PMID:29269412]. In the vasculature, STXBP5 interacts with syntaxin-4 to inhibit endothelial Weibel-Palade body exocytosis of von Willebrand factor while promoting platelet granule secretion, and a human GWAS variant (N436S) has been functionally validated to lower plasma vWF and thrombosis in CRISPR knock-in mice [PMID:25244095, PMID:28062498].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"The discovery of tomosyn as a syntaxin-1-binding protein that displaces Munc18 and inhibits Ca²⁺-dependent exocytosis established the founding principle that a soluble factor can negatively regulate SNARE-mediated fusion.\",\n      \"evidence\": \"Co-immunoprecipitation, biochemical fractionation, and PC12 overexpression exocytosis assay\",\n      \"pmids\": [\"9620695\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of inhibition (SNARE competition vs. other) not yet defined\", \"No structural information on the tomosyn-syntaxin interaction\", \"In vivo relevance not demonstrated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstration that the C-terminal VAMP-like domain forms a stable four-helical SNARE bundle with syntaxin-1/SNAP-25 — competing directly with synaptobrevin — resolved the molecular mechanism of tomosyn's inhibitory activity and extended its scope to non-neuronal t-SNAREs (syntaxin-4/SNAP-23).\",\n      \"evidence\": \"In vitro reconstitution with recombinant proteins, CD spectroscopy, competition assays; parallel yeast two-hybrid and GLUT4 translocation assays in adipocytes\",\n      \"pmids\": [\"12782620\", \"12832401\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of the large N-terminal WD40 domain unknown\", \"No atomic-resolution structure yet\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The crystal structure of the tomosyn SNARE complex at 2.0 Å, together with electrophysiological evidence that tomosyn inhibits the vesicle priming step without affecting docking, defined tomosyn as a decoy R-SNARE that traps syntaxin in a non-productive complex at the priming stage.\",\n      \"evidence\": \"X-ray crystallography and CD spectroscopy; capacitance measurements and amperometry in chromaffin cells\",\n      \"pmids\": [\"15316007\", \"14983051\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Priming inhibition could involve additional WD40-dependent mechanisms\", \"Regulation of tomosyn activity not addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of PKA-mediated phosphorylation of tomosyn — which reduces syntaxin binding and enhances neurotransmitter release — and ROCK-mediated phosphorylation of syntaxin-1 — which increases tomosyn affinity — revealed that opposing kinase pathways bidirectionally tune tomosyn's inhibitory function.\",\n      \"evidence\": \"In vitro kinase assays, co-immunoprecipitation, electrophysiology in SCG neurons; ROCK kinase assays and growth cone imaging\",\n      \"pmids\": [\"16186257\", \"15240567\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphorylation sites on tomosyn for PKA not fully mapped\", \"In vivo significance of ROCK-tomosyn axis in neurons not established\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetic loss of the C. elegans ortholog tom-1 confirmed the conserved role of tomosyn as a negative regulator of vesicle priming in vivo, and epistasis with unc-13 placed tomosyn functionally downstream of the priming machinery.\",\n      \"evidence\": \"Electrophysiology, electron microscopy, and genetic epistasis in C. elegans\",\n      \"pmids\": [\"16895441\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian genetic loss-of-function not yet available\", \"Whether the WD40 or SNARE domain mediates in vivo priming inhibition unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Structure–function dissection in chromaffin cells unexpectedly showed that the N-terminal WD40 domain, not the C-terminal SNARE domain, is the primary determinant of vesicle priming inhibition, challenging the SNARE-competition-only model.\",\n      \"evidence\": \"Domain deletion mutant overexpression with capacitance measurements in chromaffin cells\",\n      \"pmids\": [\"17666050\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which WD40 domain inhibits priming not identified\", \"Apparent contradiction with SNARE-domain-centric model not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The discovery that the WD40 domain catalyzes oligomerization of SNARE complexes provided a second, distinct inhibitory mechanism and reconciled the WD40-dependent priming inhibition with the SNARE-domain competition model as dual, complementary pathways.\",\n      \"evidence\": \"Microinjection into neurons, biochemical analysis of SNARE complex oligomerization, tomosyn-deficient mouse neurons\",\n      \"pmids\": [\"18936251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of WD40-mediated SNARE oligomerization unknown\", \"Relative contributions of the two mechanisms in different cell types not quantified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"A convergence of studies in 2014 established STXBP5's vascular function — inhibiting endothelial Weibel-Palade body exocytosis of vWF via syntaxin-4 while promoting platelet granule secretion via syntaxin-11/SNAP-23 — and demonstrated that the NTD recruits tomosyn to fusion sites while the CTD blocks v-SNARE pairing in reconstituted fusion.\",\n      \"evidence\": \"Stxbp5 KO mouse with thrombosis/bleeding phenotypes, siRNA in endothelial cells, co-IP with syntaxin-4 and syntaxin-11, reconstituted liposome fusion with purified full-length protein\",\n      \"pmids\": [\"25244095\", \"25244094\", \"25063806\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why tomosyn promotes platelet secretion but inhibits endothelial secretion mechanistically unclear\", \"Role of specific platelet SNARE isoforms not fully dissected\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of SUMOylation (by PIASγ, SUMO-2/3 at K730) and phosphorylation-dependent ubiquitin-proteasomal degradation (by Hrd-1 E3 ligase) of tomosyn established post-translational control of tomosyn protein levels and activity as a regulatory layer for insulin secretion.\",\n      \"evidence\": \"SUMO modification assays, yeast two-hybrid with PIASγ, mass spectrometry-mapped phosphosites, ubiquitination assays with Hrd-1\",\n      \"pmids\": [\"24614299\", \"25002582\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo significance of SUMOylation for insulin secretion not demonstrated in animal models\", \"Whether Hrd-1 regulation applies to tomosyn-1 (not just tomosyn-2) was not shown at this point\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Akt phosphorylation at Ser-783 was shown to relieve tomosyn's inhibition of syntaxin-4 interaction, linking insulin/PI3K signaling directly to derepression of GLUT4 exocytosis, while tomosyn knockdown at hippocampal mossy fiber synapses revealed a role in synaptic facilitation and LTP.\",\n      \"evidence\": \"In vitro kinase assay with Akt, GLUT4 surface assay; shRNA/optogenetic approach with slice electrophysiology\",\n      \"pmids\": [\"25725259\", \"26166572\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo validation of Akt-tomosyn axis in adipose tissue lacking\", \"Mechanism by which tomosyn loss impairs facilitation (expected to enhance release) not fully explained\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Multiple regulatory layers were defined: glucose-dependent de-SUMOylation at K298 releases syntaxin-1A in beta cells; secretagogin dissociates from tomosyn upon Ca²⁺ to promote exocytosis; HRD1 ubiquitinates tomosyn-1 to control dendritic spine density; and the human GWAS variant N436S was validated by CRISPR knock-in to reduce vWF and thrombosis.\",\n      \"evidence\": \"SUMO mutagenesis and insulin secretion in human beta cells; HRD1 in vitro ubiquitination and spine analysis in neurons; CRISPR/Cas9 knock-in mouse for N436S\",\n      \"pmids\": [\"28325894\", \"29269412\", \"28062498\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for how N436S alters tomosyn function unknown\", \"Role of secretagogin-tomosyn axis beyond beta cells not explored\", \"Spine density effect appears SNARE-domain-independent — mechanism unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Reconstitution of the full SNARE assembly pathway showed that NSF/α-SNAP disassembles the tomosyn-syntaxin arrest, enabling Munc18-1 binding, after which Munc13-1 selectively channels syntaxin toward synaptobrevin rather than tomosyn — placing tomosyn within the ordered priming cascade.\",\n      \"evidence\": \"In vitro reconstitution with purified NSF, α-SNAP, Munc18-1, Munc13-1, and tomosyn\",\n      \"pmids\": [\"29485200\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Order of events not validated in intact synapses\", \"Whether Munc13-1 selectivity applies to all tomosyn isoforms untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"CRISPR double KO of both tomosyn genes in adipocytes confirmed their non-redundant inhibition of all SNARE complexes underlying GLUT4 exocytosis, while neuronal studies revealed a SNARE-independent function: tomosyn's WD40 domain inhibits RhoA GTPase to maintain dendritic arborization and AMPA receptor surface expression, with ASD-associated WD40 variants showing loss of this function.\",\n      \"evidence\": \"CRISPR-Cas9 DKO adipocytes with reconstituted liposome fusion; shRNA in primary neurons with RhoA activity assay, surface AMPAR staining, and ASD variant rescue\",\n      \"pmids\": [\"32851733\", \"32133675\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which WD40 domain inhibits RhoA (direct or indirect) not defined\", \"ASD variant effects not validated in animal behavior\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Conditional double KO of Stxbp5/Stxbp5l in mouse neurons unexpectedly revealed that tomosyns regulate dense-core vesicle biogenesis at the trans-Golgi network — decreasing DCV cargo levels without affecting fusion — a function independent of the SNARE domain, expanding tomosyn's role beyond fusion inhibition.\",\n      \"evidence\": \"Conditional DKO mouse, pHluorin single-vesicle DCV assay, electron microscopy, live TGN imaging\",\n      \"pmids\": [\"37695731\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of TGN cargo sorting regulation unknown\", \"Which WD40-interacting partners at the TGN mediate this effect not identified\", \"Relevance to synaptic vesicle cargo not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include: the structural basis for WD40-mediated SNARE oligomerization and RhoA inhibition; how tomosyn simultaneously promotes platelet secretion while inhibiting endothelial exocytosis; the mechanism underlying tomosyn's role in DCV biogenesis at the TGN; and whether ASD-associated WD40 variants cause behavioral phenotypes in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of full-length tomosyn or WD40 domain in complex with SNARE oligomers\", \"Cell-type-specific functions (promote vs. inhibit secretion) mechanistically unexplained\", \"DCV biogenesis pathway partners unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [1, 2, 16]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3, 6, 10, 29]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 12]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [12, 18]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [33]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [34]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 3, 5, 6, 10, 20]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 7, 14, 29]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [14, 15, 23]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5, 21, 28]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [13, 17, 25, 31]}\n    ],\n    \"complexes\": [\n      \"tomosyn-syntaxin-1-SNAP-25 ternary SNARE complex\",\n      \"tomosyn-syntaxin-4-SNAP-23 ternary SNARE complex\"\n    ],\n    \"partners\": [\n      \"STX1A\",\n      \"SNAP25\",\n      \"STX4\",\n      \"SNAP23\",\n      \"STX11\",\n      \"SYNGR1\",\n      \"HRD1\",\n      \"SCGN\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}